The latest price target for Quest Diagnostics (NYSE:DGX) was reported by JP Morgan on May 6, 2025. The analyst firm set a price target for $190.00 expecting DGX to rise to within 12 months (a ...

With a market cap of $18.9 billion, Quest Diagnostics Incorporated (DGX) is a leading provider of diagnostic testing services ...

Zacks Research analyst R. Department now expects ... Redburn Atlantic assumed coverage on Quest Diagnostics in a research note on Wednesday, April 2nd. They set a “buy” rating and a $195. ...

The standing of Quest Diagnostics among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations ...

Jefferies starts Quest Diagnostics with buy, $185 target Open in App ...

Decoding Analyst Ratings: A Detailed Look A comprehensive examination of how financial experts perceive Quest Diagnostics is derived from recent analyst actions. The following is a detailed ...

Adjusted diluted EPS stood at $2.04, consistent with the prior year and aligning with analyst projections. Quest Diagnostics Q1 2024 Earnings: Aligns with Analyst EPS Projections, Raises Full-Year ...

InvestingPro offers comprehensive analysis of Quest Diagnostics’ performance, including 8 additional ProTips and detailed financial metrics in its Pro Research Report, part of its coverage of ...

James Davis; Executive Chairman of the Board, President, Chief Executive Officer; Quest Diagnostics Inc Sam Samad; Chief Financial Officer, Executive Vice President; Quest Diagnostics Inc Welcome ...